NASDAQ
1.02USD
-0.06 (-5.56%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
6.7M
P/E
—
EPS
—
Beta
3.74
52W range
0.777-9.48
Day range
1.00–1.04
Open
1.02
Prev close
1.08
Volume
44.3K
Avg volume
402.5K
Dividend
0.00
IPO
2018-05-22
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Exicure, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for XCUR: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
